Sign inJoin waitlistJoin the waitlist

AM

Amir Mortazavi

Physician · Ohio State University College of Medicine

Credentials: · · ·

History

Ohio State University College of Medicine
Present

Medical Oncology
1994–1996
Internal Medicine
1991–1994
Doctor of Medicine
1987–1991

Research

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 571 citations
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
Cancer Discovery · 2018 · 215 citations
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021
Journal of the National Comprehensive Cancer Network · 2020 · 202 citations

PM
Paul Monk
20 papers
Steven Clinton
15 papers
Sumanta Pal
14 papers
Katharine Collier
13 papers · 3 as a fellow
Elaine Lam
12 papers
YY
Yuanquan Yang
11 papers
Debra Zynger
9 papers · 2 as a fellow
Toni Choueiri
9 papers
Neeraj Agarwal
8 papers
Primo Lara
8 papers
Rana McKay
8 papers · 1 as a resident
Saby George
8 papers

Clinical trials

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Principal investigator · Completed · Phase 1
Amir Mortazavi
2010–2017
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2019–2027